BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8688498)

  • 21. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis.
    Cavalcante P; Barberis M; Cannone M; Baggi F; Antozzi C; Maggi L; Cornelio F; Barbi M; Didò P; Berrih-Aknin S; Mantegazza R; Bernasconi P
    Neurology; 2010 Apr; 74(14):1118-26. PubMed ID: 20368632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis.
    Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Itoyama Y
    J Neuroimmunol; 2005 Oct; 167(1-2):186-9. PubMed ID: 16040133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological studies on human thymus. Occurrence and distribution of immunoglobulins and immunological receptors in myasthenia gravis and control patients.
    Christensson B; Matell G; Biberfeld P
    Acta Med Scand; 1980; 208(3):161-8. PubMed ID: 7001861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodetection of the thymic epithelial P19 antigen in cultures of normal and pathological human thymic epithelium.
    Cohen-Kaminsky S; Berrih-Aknin S; Savino W; Dardenne M
    Thymus; 1987; 9(4):225-38. PubMed ID: 3313829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
    Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
    Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia.
    Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R
    J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinico-immunological features of generalized myasthenia in patients with hyperplasia and atrophy of the thymus gland].
    Vetshev PS; Zaĭrat'iants OV; Ippolitov IKh; Belokrinitskiĭ DV; Shkrob LO; Khodzhaev ZSh; Kurochkin AV
    Klin Med (Mosk); 1991 Dec; 69(12):78-83. PubMed ID: 1787688
    [No Abstract]   [Full Text] [Related]  

  • 31. Localized thymic Langerhans' cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies.
    Gilcrease MZ; Rajan B; Ostrowski ML; Ramzy I; Schwartz MR
    Arch Pathol Lab Med; 1997 Feb; 121(2):134-8. PubMed ID: 9126040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic imaging and therapy in a case of myasthenia gravis associated with thymic hyperplasia.
    Foschi R; Rinaldi P; Meduri A; Campioni P; Pirronti T
    Rays; 2003; 28(4):369-78. PubMed ID: 15152539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
    Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H
    Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. True thymic hyperplasia versus follicular thymic hyperplasia: a retrospective analysis of 13 cases.
    Mlika M; Ayadi-Kaddour A; Marghli A; Ismail O; Kilani T; El Mezni F
    Pathologica; 2009 Oct; 101(5):175-9. PubMed ID: 20218057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymus involvement in early-onset myasthenia gravis.
    Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
    Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironments in the normal thymus and the thymus in myasthenia gravis.
    Bofill M; Janossy G; Willcox N; Chilosi M; Trejdosiewicz LK; Newsom-Davis J
    Am J Pathol; 1985 Jun; 119(3):462-73. PubMed ID: 3874554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ultrastructural study of the thymus in patients with myasthenia gravis].
    Li SX; Hu ZL; Zeng LQ
    Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):310-2. PubMed ID: 8269758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
    Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
    Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosa-associated lymphoid tissue of the thymus hyperplasia vs lymphoma.
    Parrens M; Dubus P; Danjoux M; Jougon J; Brousset P; Velly JF; de Mascarel A; Merlio JP
    Am J Clin Pathol; 2002 Jan; 117(1):51-6. PubMed ID: 11789730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.
    Kirchner T; Schalke B; Melms A; von Kügelgen T; Müller-Hermelink HK
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):237-57. PubMed ID: 2879380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.